with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000

contribute to the segment earnings. However, contribution from this business will be adversely impacted in 2Q19 due to an unplanned shutdown lasting for around 45 days. 2020 will be the year that IVL realize

HVA continues to contribute to the segment earnings. However, contribution from this business will be adversely impacted in 2Q19 due to an unplanned shutdown lasting for around 45 days. 2020 will be the

13.25 Million or 32.15% compared with the same period of last year. The income statement in brief is presented as following: Unit : Million THB Revenues from Sale 341.59 100.00% 120.13 100.00% 221.46

with the same period of last year. The income statement in brief is presented as following: Unit : Million THB Revenues from Sale 391.51 100.00% 217.59 100.00% 173.92 79.93% Cost of Sales 215.40 55.02

guidelines for investors to understand and monitor future business directions of the Company; 1.1.2 Material changes and developments Give a brief account on the material changes and developments regarding the

the Company; 1.1.2 Material changes and developments Give a brief account on the material changes and developments regarding the controlling power and the nature of business during the preceding year as

appointment date may be notified less than the said. In making the oral statement, the appellant shall file with the SEC a brief statement on or before the appointment date. The brief statement shall not

debt. In order to manage the company’s working capital to coincide with operations. As well as, managing debts to be paid on time. The company was able to secure funds, both short term loans and long

and long term), including: (a) a description of the internal and external sources of liquidity and a brief discussion of any material unused sources of liquidity. Include a statement by the issuer that